Can antibodies against neuronal surface and synaptic proteins disrupt signaling and cause reversible cognitive or behavioral dysfunction?

Autoantibodies directed against neuronal surface and synaptic targets are a biologically credible cause of disturbed neurotransmission and can occur in autoimmune encephalitis syndromes presenting with subacute cognitive, psychiatric, or behavioral change. Their clinical relevance depends on the antibody target, phenotype, and supporting neurologic investigations—not antibody positivity alone.

Mechanistic evidence

• NMDAR and AMPAR antibodies can cross-link receptors, promote internalization, reduce synaptic receptor clusters, and diminish receptor-mediated currents. For NMDAR antibodies, impaired EphB2-associated stabilization and increased receptor lateral diffusion may further reduce synaptic availability; these experimental effects are titer-dependent and reversible.
• GABA_A receptor and glycine-receptor antibodies may reduce surface/synaptic receptor abundance and can also directly inhibit inhibitory currents.
• Functional disruption does not invariably require receptor loss: GABA_B receptor antibodies can impair receptor responses, including baclofen responses, despite preserved measured surface expression.
• CASPR2 antibodies, often predominantly IgG4, can block the CASPR2–contactin-2/TAG-1 interaction without reducing CASPR2 surface levels. This may disturb Kv1-channel organization and neuronal repolarization; other CASPR2 antibody preparations have been associated with reduced synaptic CASPR2 and AMPAR internalization.

Clinical interpretation

• A genuine autoimmune encephalitis syndrome can include subacute memory, cognition, mood, psychosis, or behavioral disturbance and may improve with appropriate treatment, consistent with potentially reversible functional synaptic dysfunction rather than obligatory irreversible neuronal loss.
• Improvement is not assured: persistent cognitive, mood, sleep, fatigue, or other neuropsychiatric symptoms can remain and merit serial objective assessment and rehabilitation.

Diagnostic implications

• Especially in an older adult with cognitive symptoms, attribution requires a phenotype-concordant syndrome plus supportive MRI, EEG, and/or CSF findings and assessment for infectious, metabolic, neoplastic, and other mimics.
• Paired serum and CSF testing is important; weak or serum-only results may be clinically irrelevant or false-positive.

Bottom line

• Surface/synaptic autoantibodies can directly disrupt receptor localization or signaling through several well-supported mechanisms. Cognitive and behavioral dysfunction can be potentially reversible in bona fide autoimmune encephalitis, but the extent and target-specific likelihood of recovery are not established.